Your browser doesn't support javascript.
loading
Pancreatic Adenocarcinoma Therapeutics Targeting RTK and TGF Beta Receptor.
Yang, Hsin-Han; Liu, Jen-Wei; Lee, Jui-Hao; Harn, Horng-Jyh; Chiou, Tzyy-Wen.
Affiliation
  • Yang HH; Department of Life Science and Graduate Institute of Biotechnology, National Dong Hwa University, Hualien 974, Taiwan.
  • Liu JW; Everfront Biotech Inc., New Taipei City 221, Taiwan.
  • Lee JH; Everfront Biotech Inc., New Taipei City 221, Taiwan.
  • Harn HJ; Bioinnovation Center, Tzu Chi Foundation, Buddhist Tzu Chi General Hospital, Tzu Chi University, Hualien 970, Taiwan.
  • Chiou TW; Department of Pathology, Buddhist Tzu Chi General Hospital, Tzu Chi University, Hualien 970, Taiwan.
Int J Mol Sci ; 22(15)2021 Jul 29.
Article in En | MEDLINE | ID: mdl-34360896

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Signal Transduction / Receptors, Transforming Growth Factor beta / Receptor Protein-Tyrosine Kinases / Carcinoma, Pancreatic Ductal / Protein Kinase Inhibitors / Antineoplastic Agents Limits: Humans Language: En Journal: Int J Mol Sci Year: 2021 Document type: Article Affiliation country: Taiwán Country of publication: Suiza

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Signal Transduction / Receptors, Transforming Growth Factor beta / Receptor Protein-Tyrosine Kinases / Carcinoma, Pancreatic Ductal / Protein Kinase Inhibitors / Antineoplastic Agents Limits: Humans Language: En Journal: Int J Mol Sci Year: 2021 Document type: Article Affiliation country: Taiwán Country of publication: Suiza